The plant, operated through a 15-year agreement between AstraZeneca and UK-based biomethane producer Future Biogas, will supply 100 gigawatt hours (GW) of renewable energy per year for AstraZeneca ...

AstraZeneca Plc (NASDAQ:AZN) is reportedly reconsidering its planned $578.4 million (450 million pounds) investment in a new vaccine-manufacturing site, a departure from CEO Pascal Soriot‘s ...

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing concerns over NHS drug pricing and industry tensions.

The plant, which will operate 24/7, will generate enough biomethane to heat the equivalent of over 8,000 homes a year and boost the UK's green energy capacity. This is another step towards the ...

She went on to say AstraZeneca will adjust capacity to meet demand, adding, “The investment is part of a broader $3.5 billion commitment to U.S. research and manufacturing.” Essential control ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support.

A multi-million dollar vaccine plant being built in the U.K. by AstraZeneca is under threat amid reports the Treasury could cut the state aid being offered.

LONDON (AP) — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...

AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine ...